UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 5, 2005
VISUALMED CLINICAL SOLUTIONS CORP.
(Exact name of registrant as specified in its charter)
Nevada |
000-33191 |
88-0436055 |
(State or other
jurisdiction of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
1035 Laurier St. West, Suite 200,
Montreal, Quebec, Canada (Address of principal executive offices) |
H2V 2L1 (Zip Code) |
|
(514) 274-1115
(Registrant’s telephone
number, including area code)
___________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
|
|
£ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
£ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
£ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| £ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
On October 5, 2005, VisualMED Clinical Solutions Corp. (the “Company”) issued a press release announcing that its annual report reflected a very active year. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
The information furnished under Item 7.01 “Regulation FD Disclosure” shall not be deemed “filed” for purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
| (d) |
Exhibits. |
|
||
| 99.1 |
- |
Press Release of VisualMED Clinical Solutions Corp., dated October 5, 2005. |
||
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
October 5, 2005 |
VISUALMED
CLINICAL SOLUTIONS CORP. |
|
| By: | /s/ Gerard Dab | ||
| Gerard Dab Principal Executive Officer, Secretary and a member of the Board of Directors |
|||
3
Exhibit Index
| Exhibit No. |
Description |
99.1 - |
Press Release of VisualMED Clinical Solutions Corp., dated October 5, 2005. |
4